Japanese
English
- 有料閲覧
PPV購入案内
1,320円 (1,200円+税10%) こちらは、1087ページから1093ページの文献です。購入には医書.jp本会員登録が必要です。
会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。
会員登録について詳しくはをご確認ください。
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
Point
・他家血液・組織由来の医療材料を使用する際には,感染のリスクを考慮する必要がある.
・創部感染を予防するために抗菌性を備えた医療材料が開発され,その有効性を検証するために多くの研究が行われている.
Surgery has the possibility to cause infections. Surgical site infection(SSI)is a common complication of various surgical procedures. On the other hand, allogeneic tissue-derived material-induced infections, such as transfusion-related hepatitis and Creutzfeldt-Jakob disease, are rare but occur. The risk of surgery-related infections needs to be reduced because such infections not only affect morbidity and mortality but also lead to increased medical costs and longer hospitalization. Recently, various allogeneic and synthetic medical materials have been developed, and many types of materials have been used in daily neurosurgical procedures. Some synthetic materials have been advertised to have an SSI-preventive effect. Technology has also been developed to minimize the infectivity of allogeneic materials. In this paper, we introduce some information focused on the infectivity of fibrin glue and DuraGen® and the SSI-preventive effect of Surgicel® and antimicrobial sutures.

Copyright © 2022, Igaku-Shoin Ltd. All rights reserved.

